Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Chie EK"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 61
Tytuł:
Cancer-associated mesenchymal stem cells aggravate tumor progression
Autorzy:
Chie eKudo-Saito
Pokaż więcej
Temat:
Immunosuppression
Cancer
metastasis
mesenchymal stem cell
epithelial-to-mesenchymal transition
Biology (General)
QH301-705.5
Źródło:
Frontiers in Cell and Developmental Biology, Vol 3 (2015)
Opis pliku:
electronic resource
Relacje:
http://journal.frontiersin.org/Journal/10.3389/fcell.2015.00023/full; https://doaj.org/toc/2296-634X
Dostęp URL:
https://doaj.org/article/586510ab2e134f228a8e752d29a27d4f  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Assessment of lymph node area coverage with total marrow irradiation and implementation of total marrow and lymphoid irradiation using automated deep learning-based segmentation.
Autorzy:
Choi HS; Department of Radiation Oncology, Seoul National University Hospital, Seoul, South Korea.; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, South Korea.
Kang HC; Department of Radiation Oncology, Seoul National University Hospital, Seoul, South Korea.; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, South Korea.
Chie EK; Department of Radiation Oncology, Seoul National University Hospital, Seoul, South Korea.; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, South Korea.
Shin KH; Department of Radiation Oncology, Seoul National University Hospital, Seoul, South Korea.; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, South Korea.
Chang JH; Department of Radiation Oncology, Seoul National University Hospital, Seoul, South Korea.; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, South Korea.
Jang BS; Department of Radiation Oncology, Seoul National University Hospital, Seoul, South Korea.; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, South Korea.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 08; Vol. 19 (3), pp. e0299448. Date of Electronic Publication: 2024 Mar 08 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Deep Learning*
Radiotherapy, Intensity-Modulated*/methods
Humans ; Bone Marrow/diagnostic imaging ; Bone Marrow/radiation effects ; Lymphatic Irradiation/methods ; Radiotherapy Dosage ; Lymph Nodes/diagnostic imaging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Risk Factors for Distant Metastasis in Extrahepatic Bile Duct Cancer after Curative Resection (KROG 1814).
Autorzy:
Park Y; Department of Radiation Oncology, Ewha Womans University College of Medicine, Seoul, Korea.
Kim TH; Center for Proton Therapy, National Cancer Center, Goyang, Korea.
Kim K; Department of Radiation Oncology, Ewha Womans University College of Medicine, Seoul, Korea.
Yu JI; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Jung W; Department of Radiation Oncology, Ewha Womans University College of Medicine, Seoul, Korea.
Seong J; Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Korea.
Kim WC; Department of Radiation Oncology, Inha University School of Medicine, Incheon, Korea.
Choi JH; Department of Radiation Oncology, Chung-Ang University College of Medicine, Seoul, Korea.
Chang AR; Department of Radiation Oncology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.
Jeong BK; Department of Radiation Oncology, Gyeongsang National University College of Medicine, Jinju, Korea.
Kim BH; Department of Radiation Oncology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.
Kim TG; Department of Radiation Oncology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.
Kim JH; Department of Radiation Oncology, Keimyung University School of Medicine, Daegu, Korea.
Park HJ; Department of Radiation Oncology, Hanyang University College of Medicine, Seoul, Korea.
Shin HS; Department of Radiation Oncology, CHA University School of Medicine, Seongnam, Korea.
Im JH; Department of Radiation Oncology, CHA University School of Medicine, Seongnam, Korea.
Chie EK; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2024 Jan; Vol. 56 (1), pp. 272-279. Date of Electronic Publication: 2023 Jul 31.
Typ publikacji:
Journal Article
MeSH Terms:
Bile Duct Neoplasms*/surgery
Bile Ducts, Extrahepatic*/surgery
Bile Ducts, Extrahepatic*/pathology
Humans ; Prognosis ; Chemoradiotherapy, Adjuvant/methods ; Risk Factors ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Predicting Deterioration from Wearable Sensor Data in People with Mild COVID-19.
Autorzy:
Kang JY; Department of Medical Informatics, Keimyung University, Daegu 42601, Republic of Korea.; Department of Statistics and Data Science, Yonsei University, Seoul 03722, Republic of Korea.
Bae YS; Department of Family Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Republic of Korea.; Department of Future Healthcare Planning, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Republic of Korea.
Chie EK; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Lee SB; Department of Medical Informatics, Keimyung University, Daegu 42601, Republic of Korea.
Pokaż więcej
Źródło:
Sensors (Basel, Switzerland) [Sensors (Basel)] 2023 Dec 04; Vol. 23 (23). Date of Electronic Publication: 2023 Dec 04.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Wearable Electronic Devices*
Humans ; Self Report ; Surveys and Questionnaires ; Machine Learning
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Barriers in Oligometastasis Care in Korea: Radiation Oncologists' Perspectives.
Autorzy:
Chie EK; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Rim CH; Department of Radiation Oncology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
Cho WK; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Ahn YC; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2023 Oct; Vol. 55 (4), pp. 1063-1064. Date of Electronic Publication: 2023 Jun 27.
Typ publikacji:
Editorial
MeSH Terms:
Terminal Care*
Oncologists*
Neoplasms*
Humans ; Radiation Oncologists ; Medical Oncology ; Republic of Korea ; Attitude of Health Personnel
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Differential Perspectives by Specialty on Oligometastatic Colorectal Cancer: A Korean Oligometastasis Working Group's Comparative Survey Study.
Autorzy:
Cho WK; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Yoo GS; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Rim CH; Department of Radiation Oncology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
Jeong JU; Department of Radiation Oncology, Chonnam National University Hwasun Hospital, Chonnam National University College of Medicine, Hwasun, Korea.
Chie EK; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Ahn YC; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Cho HM; Department of Surgery, St. Vincent`s Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
Um JW; Department of Surgery, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
Suh YG; Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Chang AR; Department of Radiation Oncology, Soonchunhyang University Seoul Hospital, Seoul, Korea.
Lee JH; Department of Radiation Oncology, St Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
Pokaż więcej
Corporate Authors:
Oligometastasis Working Group, Korean Cancer Association
Źródło:
Cancer research and treatment [Cancer Res Treat] 2023 Oct; Vol. 55 (4), pp. 1281-1290. Date of Electronic Publication: 2023 Jun 07.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/therapy
Colorectal Neoplasms*/pathology
Humans ; Surveys and Questionnaires ; Consensus ; Biomarkers ; Republic of Korea
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): study protocol of a multicentre randomized controlled trial.
Autorzy:
Kim MJ; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea.
Lee DW; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Kang HC; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Park JW; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea.
Ryoo SB; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea.
Han SW; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Kim KS; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Chie EK; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Oh JH; Cancer for Colorectal Cancer, National Cancer Center, Goyang, Korea.
Jeong WK; Department of Surgery, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea.
Kim BH; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.; Department of Radiation Oncology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.
Nam EM; Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea.
Jeong SY; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea. .; Cancer Research Institute, Seoul National University, Seoul, Korea. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Aug 08; Vol. 23 (1), pp. 734. Date of Electronic Publication: 2023 Aug 08.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Neoadjuvant Therapy*/methods
Rectal Neoplasms*/pathology
Humans ; Capecitabine/therapeutic use ; Treatment Outcome ; Prospective Studies ; Quality of Life ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Neoplasm Staging ; Chemoradiotherapy/methods ; Republic of Korea/epidemiology ; Fluorouracil ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Metastasis-Directed Local Therapy of Hepatic Oligometastasis from Colorectal Cancer and Future Perspective in Radiation Therapy.
Autorzy:
Yoo GS; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Rim CH; Department of Radiation Oncology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
Cho WK; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Jeong JU; Department of Radiation Oncology, Chonnam National University Hwasun Hospital, Chonnam National University College of Medicine, Hwasun, Korea.
Chie EK; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Cho HM; Department of Surgery, St. Vincent`s Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
Um JW; Department of Surgery, Korea University Ansan Hospital, Korea University College of Medicine, Asan, Korea.
Ahn YC; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Lee JH; Department of Radiation Oncology, St. Vincent`s Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
Pokaż więcej
Corporate Authors:
Korean Cancer Association Oligometastasis Working Group; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Źródło:
Cancer research and treatment [Cancer Res Treat] 2023 Jul; Vol. 55 (3), pp. 707-719. Date of Electronic Publication: 2023 Mar 15.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/pathology
Liver Neoplasms*
Humans ; Treatment Outcome ; Hepatectomy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Genomic landscape of locally advanced rectal adenocarcinoma: Comparison between before and after neoadjuvant chemoradiation and effects of genetic biomarkers on clinical outcomes and tumor response.
Autorzy:
Lee TH; Department of Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea.; Department of Clinical Medical Science, Seoul National University College of Medicine, Seoul, Republic of Korea.
Jang BS; Department of Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea.
Chang JH; Department of Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea.
Kim E; Department of Radiation Oncology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Park JH; Department of Pathology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Chie EK; Department of Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea.; Department of Clinical Medical Science, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Republic of Korea.; Medical Research Center, Institute of Radiation Medicine, Seoul National University, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Jul; Vol. 12 (14), pp. 15664-15675. Date of Electronic Publication: 2023 Jun 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Rectal Neoplasms*/genetics
Rectal Neoplasms*/therapy
Rectal Neoplasms*/pathology
Adenocarcinoma*/genetics
Adenocarcinoma*/therapy
Adenocarcinoma*/pathology
Humans ; Neoadjuvant Therapy ; Treatment Outcome ; Biomarkers, Tumor/genetics ; Genomics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
One-Week versus Two-Week Chemoradiotherapy Followed by Curative Surgery in Rectal Cancer: Long-Term Comparative Pooled Analysis of Two Prospective Multicenter Phase II Trials.
Autorzy:
Sung SY; Department of Radiation Oncology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Kim DY; Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Jang HS; Department of Radiation Oncology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Kim TH; Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Park HC; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Chie EK; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Nam TK; Department of Radiation Oncology, Hwasun Chonnam National University Hospital, Hwasun, Korea.
Kim SH; Department of Radiation Oncology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
Lee JH; Department of Radiation Oncology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2023 Jul; Vol. 55 (3), pp. 918-926. Date of Electronic Publication: 2023 Feb 27.
Typ publikacji:
Clinical Trial, Phase II; Multicenter Study; Journal Article
MeSH Terms:
Rectal Neoplasms*/pathology
Humans ; Prospective Studies ; Fluorouracil/therapeutic use ; Chemoradiotherapy/adverse effects ; Capecitabine/therapeutic use ; Neoadjuvant Therapy ; Neoplasm Staging ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Characterization of the gene signature correlated with favorable response to chemoradiotherapy in rectal cancer: A hypothesis-generating study.
Autorzy:
Jeon SH; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea.
Chie EK; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (7), pp. 8981-8990. Date of Electronic Publication: 2023 Jan 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Rectal Neoplasms*/genetics
Rectal Neoplasms*/therapy
Rectal Neoplasms*/metabolism
Humans ; Treatment Outcome ; Chemoradiotherapy ; Neoadjuvant Therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Dosimetric evaluation of magnetic resonance imaging-guided adaptive radiation therapy in pancreatic cancer by extent of re-contouring of organs-at-risk.
Autorzy:
Song JY; Department of Radiation Oncology, Seoul National University Hospital, Seoul, Korea.; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Chie EK; Department of Radiation Oncology, Seoul National University Hospital, Seoul, Korea.; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Kang SH; Department of Radiation Oncology, Seoul National University Hospital, Seoul, Korea.
Jeon YJ; Seoul National University College of Medicine, Seoul, Korea.
Ko YA; Seoul National University College of Medicine, Seoul, Korea.
Kim DY; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.; Department of Radiation Oncology, Kyung Hee University Hospital at Gangdong, Seoul, Korea.
Kang HC; Department of Radiation Oncology, Seoul National University Hospital, Seoul, Korea.; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Radiation oncology journal [Radiat Oncol J] 2022 Dec; Vol. 40 (4), pp. 242-250. Date of Electronic Publication: 2022 Dec 26.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Role of Local Treatment for Oligometastasis: A Comparability-Based Meta-Analysis.
Autorzy:
Rim CH; Department of Radiation Oncology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
Cho WK; Department of Radiation Oncology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Lee JH; Department of Radiation Oncology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
Kim YS; Department of Radiation Oncology, Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea.
Suh YG; Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Kim KH; Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Chie EK; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Ahn YC; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Pokaż więcej
Corporate Authors:
Oligometastasis Working Group, Korea Cancer Association
Źródło:
Cancer research and treatment [Cancer Res Treat] 2022 Oct; Vol. 54 (4), pp. 953-969. Date of Electronic Publication: 2022 Aug 16.
Typ publikacji:
Journal Article; Meta-Analysis
MeSH Terms:
Lymphoma, Follicular*
Humans ; Progression-Free Survival
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Radiation Response Prediction Model Based on Integrated Clinical and Genomic Data Analysis.
Autorzy:
Jang BS; Department of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam, Korea.
Chang JH; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Jeon SH; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea.
Song MG; Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
Lee KH; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Im SA; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Kim JI; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.
Kim TY; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Chie EK; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.; Institute of Radiation Medicine, Medical Research Center, Seoul National University, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2022 Apr; Vol. 54 (2), pp. 383-395. Date of Electronic Publication: 2021 Aug 24.
Typ publikacji:
Journal Article
MeSH Terms:
Data Analysis*
Neoplasms*
Bayes Theorem ; Genomics ; Humans ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer.
Autorzy:
Lee KH; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea.
Chie EK; Department of Radiation Oncology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.; Institute of Radiation Medicine, Medical Research Center, Seoul National University, Seoul, Korea.
Im SA; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea.
Kim JH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Kwon J; Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, Korea.
Han SW; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea.
Oh DY; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea.
Jang JY; Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Kim JS; Department of Radiation Oncology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Kim TY; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea.
Bang YJ; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea.
Kim SW; Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Ha SW; Department of Radiation Oncology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.; Institute of Radiation Medicine, Medical Research Center, Seoul National University, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2021 Oct; Vol. 53 (4), pp. 1096-1103. Date of Electronic Publication: 2020 Dec 30.
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Multicenter Study
MeSH Terms:
Postoperative Care*
Adenocarcinoma/*therapy
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Chemoradiotherapy/*mortality
Chemotherapy, Adjuvant/*mortality
Pancreatic Neoplasms/*therapy
Adenocarcinoma/pathology ; Adolescent ; Adult ; Aged ; Cisplatin/administration & dosage ; Deoxycytidine/administration & dosage ; Deoxycytidine/analogs & derivatives ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Pancreatic Neoplasms/pathology ; Prognosis ; Survival Rate ; Young Adult ; Gemcitabine
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The Rise of Particle Beam Therapy: Are We Ready for The Potential Game-Changer?
Autorzy:
Chie EK; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.; Institute of Radiation Medicine, Medical Research Center, Seoul National University, Seoul, Korea.
Ahn YC; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.; Department of Medical Device Management and Research, SAIHST, Sungkyunkwan University, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2021 Jul; Vol. 53 (3), pp. 609-610. Date of Electronic Publication: 2021 Jun 16.
Typ publikacji:
Editorial
MeSH Terms:
Dose Fractionation, Radiation*
Neoplasms/*radiotherapy
Radiation Oncology/*methods
Humans
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine versus FOLFIRINOX.
Autorzy:
Choi YJ; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Byun Y; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Kang JS; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Kim HS; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Han Y; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Kim H; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Kwon W; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Oh DY; Departments of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Paik WH; Departments of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Lee SH; Departments of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Ryu JK; Departments of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Kim YT; Departments of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Lee K; Departments of Pathology, Seoul National University College of Medicine, Seoul, Korea.
Kim H; Departments of Pathology, Seoul National University College of Medicine, Seoul, Korea.
Chie EK; Departments of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Jang JY; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Gut and liver [Gut Liver] 2021 May 15; Vol. 15 (3), pp. 466-475.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Adenocarcinoma*/drug therapy
Pancreatic Neoplasms*/drug therapy
Antineoplastic Combined Chemotherapy Protocols ; Deoxycytidine/analogs & derivatives ; Fluorouracil ; Humans ; Irinotecan/therapeutic use ; Leucovorin/therapeutic use ; Neoadjuvant Therapy ; Neoplasm Recurrence, Local ; Oxaliplatin/therapeutic use ; Retrospective Studies ; Gemcitabine
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 61

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies